The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 181: 11-16.
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Chauvin, C.
Right arrow Articles by Josien, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chauvin, C.
Right arrow Articles by Josien, R.

Dendritic Cells as Killers: Mechanistic Aspects and Potential Roles1

Camille Chauvin2,*,{dagger},{ddagger} and Régis Josien3,*,{dagger},{ddagger},§

* Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 643, Nantes, France; {dagger} Université de Nantes, Faculté de Médecine, Nantes, France; {ddagger} Centre Hospitalier Universitaire de Nantes, Institut de Transplantation et de Recherche en Transplantation and § Laboratoire d’Immunologie, Nantes, France

Dendritic cells (DC) are professional APC endowed with the unique capacity to activate naive T cells. DC also have important effector functions during the innate immune response, such as pathogen recognition and cytokine production. In fact, DC represent the crucial link between innate and adaptive immune responses. However, DC are quite heterogeneous and various subsets endowed with specific pathogen recognition mechanisms, locations, phenotypes, and functions have been described both in rodents and in humans. A series of studies indicated that rodent as well as human DC could also mediate another important innate function, i.e., cell-mediated cytotoxicity, mostly toward tumor cells. In this article, we will review the phenotypes of these so-called killer DC, their killing mechanism, and putative implication in the immune response.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Our work was supported by Institut National de la Santé et de la Recherche Médicale and the Association pour la Recherche sur le Cancer.

2 Current address: Nuffield Department of Surgery, John Radcliffe Hospital, Headington, Oxford OX3 9DU, U.K.

3 Address correspondence and reprint requests to Dr. Régis Josien, Institut National de la Santé et de la Recherche Médicale, Unité 643, Institut de Transplantation et de Recherche en Transplantation, Centre Hospitalier Universitaire de Nantes, 30 Boulevard Jean Monnet, 44093 Nantes Cedex 1, France. E-mail address: Regis.Josien{at}univ-nantes.fr

4 Abbreviations used in this paper: DC, dendritic cell; cDC, conventional DC; FasL, Fas ligand; Gzm, granzyme; IKDC, IFN-producing killer DC; KDC, killer DC; LN, lymph node; MHCII, MHC class II; MoDC, monocyte-derived DC; mDC, myeloid DC; pDC, plasmacytoid DC.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.